Gunta Dravniece

2 ta ish

TuBerculosis Vaccine Initiative

1. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

   ABIABI:AkademIndex/2019.article.000020

2. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   PreprintOAOchiq kirishTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos

   ABIABI:AkademIndex/2024.preprint.000046